Investment
Features
FeesSafety
Academy
More
Pluang+

Dogness CEO cuts salary by 50% to align leadership with shareholder interests

Company Fundamentals
04 Sep 2026
PRNewsWire
View Source
Neutral
Dogness CEO cuts salary by 50% to align leadership with shareholder interests

Dogness International Corporation announced that its CEO, Silong Chen, has voluntarily reduced his monthly base salary from $10,000 to $5,000 starting September 1, 2026. This move is intended to build a leaner organization and align leadership compensation with shareholder interests, reflecting confidence in the company's future. Dogness, known for its pet products and strong R&D capabilities, aims to strengthen its business by sharing both risks and rewards at the leadership level. The company continues to focus on innovation and global market presence amid various business risks and uncertainties.

More News

UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

UBS Group AG has officially notified that it holds 7,768,727 shares in Bang & Olufsen A/S, representing 5.27% of the company's total share capital and voting rights as of October 9, 2026. This disclosure is made in compliance with the Danish Capital ...

Market News
Neutral
56 minutes ago
Admiral Group directors acquire shares via dividend reinvestment plan on Oct 14, 2026

Admiral Group directors acquire shares via dividend reinvestment plan on Oct 14, 2026

On October 14, 2026, Michael Brierley, a Non-Executive Director of Admiral Group plc, and his wife Rachel Brierley acquired shares of the company through a dividend reinvestment trading plan. The transactions involved purchasing ordinary shares at pr...

Company Fundamentals
Neutral
1 hour ago
Norsk Hydro to release Q3 2026 results on Oct 23 with live webcast presentation.

Norsk Hydro to release Q3 2026 results on Oct 23 with live webcast presentation.

Norsk Hydro will publish its third-quarter 2026 financial results on October 23, 2026, at 07:00 CEST. The company's CEO and CFO will present the results via a live webcast at 08:30 CEST the same day, allowing investors to ask questions online. There ...

Company Fundamentals
Neutral
1 hour ago
FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions...

Market News
Bullish
2 hours ago
NEAR Protocol price rises 12% after Helius CEO joins NEAR Foundation Council

NEAR Protocol price rises 12% after Helius CEO joins NEAR Foundation Council

NEAR Protocol's price surged over 12% in 24 hours, trading above $5.20 following the appointment of Helius CEO Mert Mumtaz to the NEAR Foundation Council. This move supports governance as the Foundation expands privacy and cross-chain trading feature...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App